Abiopharma

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Rosen Law Firm Urges Integer Holdings Corporation (NYSE: ITGR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

Cycle Pharmaceuticals to Acquire Applied Therapeutics

Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting